Functional Interaction between Human Papillomavirus Type 16 E6 and E7 Oncoproteins and Cigarette Smoke Components in Lung Epithelial Cells by Muñoz, Juan Pablo et al.
Functional Interaction between Human Papillomavirus
Type 16 E6 and E7 Oncoproteins and Cigarette Smoke
Components in Lung Epithelial Cells
Juan Pablo Mun ˜oz
1, Carolina Gonza ´lez
1,B a ´rbara Parra
1, Alejandro H. Corvala ´n
2, Maria Lina Tornesello
3,
Yoshito Eizuru
4, Francisco Aguayo
1*
1Virology Program, Instituto de Ciencias Biome ´dicas (ICBM), Faculty of Medicine, Universidad de Chile, Santiago, Chile, 2Department of Hematology-Oncology, School of
Medicine, Pontificia Universidad Cato ´lica de Chile, Santiago, Chile, 3Molecular Biology and Viral Oncology and AIDS Reference Centre, National Cancer Institute ‘‘Fond.
Pascale’’, Naples, Italy, 4Division of Oncogenic and Persistent Viruses, Center for Chronic Viral Diseases, Kagoshima University Graduate School of Medical and Dental
Sciences, Sakuragaoka, Kagoshima, Japan
Abstract
The smoking habit is the most important, but not a sufficient cause for lung cancer development. Several studies have
reported the human papillomavirus type 16 (HPV16) presence and E6 and E7 transcripts expression in lung carcinoma cases
from different geographical regions. The possible interaction between HPV infection and smoke carcinogens, however,
remains unclear. In this study we address a potential cooperation between tobacco smoke and HPV16 E6 and E7
oncoproteins for alterations in proliferative and tumorigenic properties of lung epithelial cells. A549 (alveolar, tumoral) and
BEAS-2B (bronchial, non-tumoral) cell lines were stably transfected with recombinant pLXSN vectors expressing HPV16 E6
and E7 oncoproteins and exposed to cigarette smoke condensate (CSC) at different concentrations. HPV16 E6 and E7
expression was associated with loss of p53 stability, telomerase (hTERT) and p16
INK4A overexpression in BEAS-2B cells as
demonstrated by quantitative real-time polymerase chain reaction (qRT-PCR) and western blotting (WB). In A549 cells we
observed downregulation of p53 but not a significant increase of hTERT transcripts. In addition, the HPV16 E6/E7
transfected cell lines showed an increased proliferation rate and anchorage-independent growth in a HPV16 E6 and E7
expression-dependent manner. Moreover, both HPV16 E6/E7 and mock transfected cells showed an increased proliferation
rate and anchorage-independent growth in the presence of 0.1 and 10 mg/mL CSC. However, this increase was significantly
greater in HPV16 E6/E7 transfected cells (p,0.001). Data were confirmed by FCSE proliferation assay. The results obtained in
this study are suggestive of a functional interaction between tobacco smoke and HPV16 E6/E7 oncoproteins for malignant
transformation and tumorigenesis of lung epithelial cells. More studies are warranted in order to dissect the molecular
mechanisms involved in this cooperation.
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Introduction
Human Papilloma Virus (HPV) infection and persistence are
the necessary conditions for cervix-uterine cancer development
[1,2]. In addition, HPV has been identified as an etiological agent
in a subset of head and neck cancers [3] and has been detected in
extragenital tumors such as those affecting the esophagus and
lungs, among others [4]. The establishment of an etiological
association between HPV and lung cancer has been difficult
because of the high variability of HPV prevalence in lung tumors
from one country to another [5]. Moreover, it is known that lung
cancer development is strongly and directly related to tobacco
smoking or cigarette smoke exposition. However, a very low
percentage of heavy smokers finally develop lung cancer,
suggesting that other co-factors are necessary [6]. It has been
suggested that HPV has a role as an independent carcinogen when
this virus is found in non-smoking subjects, as occurs in women of
Taiwan who develop lung adenocarcinomas [7,8]. However, other
studies have reported a variable presence of HPV in smoking
subjects who develop lung cancer [9], thus the role of HPV in
these tumors remains to be elucidated. It is plausible that HPV in
these cases might act as a co-carcinogen [10], however functional
evidence for a potential cooperation between HPV and tobacco
smoke for lung tumorigenesis is lacking.
So far, HPV16 has been the most frequent high-risk HPV
genotype found in lung carcinomas around the world [5] with
frequent E6/E7 oncogene expression [11]. High-risk HPV
integration into the host genome [12] was previously reported to
occur in lung cancer [13]. This event allows the overexpression of
E6 and E7 oncoproteins due to the loss of E2 protein, a repressor
of the p97 promoter in HPV16 [14]. The high-risk HPV E6
oncoprotein [15] is able to bind to the p53 protein, whose main
function is sensing the integrity of DNA, inducing cell cycle arrest
or apoptosis [16]. On the other hand, the high-risk HPV E7
oncoprotein [15] targets hypophosphorylated pRb for protea-
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ubiquitin ligase complex [17]. This interaction allows the release of
the transcription factor E2F, the expression of genes involved in
G1/S transition, S phase entry and therefore DNA replication
[18]. Furthermore, the specific loss of pRb leads to p16
INK4a up-
regulation by a negative feedback mechanism [19]. In addition,
high-risk E6 oncoprotein in collaboration with E7 are associated
with alterations in the level and activity of telomerase (hTERT)
[20].
The oncogenic role of tobacco smoking and cigarette smoke
components (CSC) in lung cancer has been demonstrated in
previous epidemiological and functional studies [21]. Even though
the molecular mechanisms of tobacco smoke-associated carcino-
genesis remain unclear, it has been established that benzopyrene, a
polycyclic aromatic hydrocarbon (PAH) and potent carcinogen,
activates the epidermal growth factor receptor (EGFR) and cell
proliferation [22]. In addition, functional studies using organotypic
cultures have demonstrated that benzopyrene, depending on its
concentration, is able to increase the number of virions and
genomes of HPV [23]. Using high concentrations of benzopyrene,
virion synthesis is allowed. However, at low concentrations HPV
genomes are amplified. The authors suggested that cyclin-
dependent kinase 1 (CDK1), activated after incubation with
benzopyrene may be involved in virion maturation; a mechanism
used by diverse viruses in morphogenesis [24]. In addition, the
same authors suggested that an increased CDK1 activity could be
involved in viral persistence in the cells. Recently it has been
reported that benzopyrene increases HPV E7 expression in a
model of cervical raft cultures [25]. In addition to functional
studies, epidemiological reports established that the smoking habit
is a co-factor working synergistically for cervical carcinogenesis
[26]. In fact, the International Agency for Research on Cancer
(IARC, Lyon, France) established that tobacco smoke is a potential
cervix-uterine carcinogen [27]. Thus the objective of this study
was to analyze a potential cooperation between HPV16 E6/E7
oncoproteins and cigarette smoke components in lung epithelial
cells exposed to both carcinogenic agents.
Results
Transfection of lung cell lines with pLXSNE6 and E7
constructs allows efficient expression of E6 and E7
transcripts and functional E6 and E7oncoproteins
Transfection of A549 and BEAS-2B lung cell lines with a
pLXSN recombinant vector containing the HPV16 E6 and E7
open reading frames (ORF) allowed an efficient and stable
expression of the corresponding transcripts (Figs. 1A and B). In
addition, both cell lines expressed similar levels of E6 and E7
transcripts that were not detected in cells transfected with the
empty vector as shown using qRT-PCR (Figs. 1C and D). The
functional activity of the E6 oncoprotein was demonstrated in both
cell lines by loss of p53 stability in HPV16 E6 and E6/E7
transfected cells as shown using WB (Fig. 2A). As control, a
semiquantitative RT-PCR assay with primers flanking the TP53
gene exon 1 showed the same level of p53 transcripts for empty
vector, E6, E7 and E6/E7 in both A549 and BEAS-2B transfected
cells (Fig. 2B). In addition A549 cells transfected with the HPV16
E7 vector showed p53 up-regulation, demonstrating functional
activity of this oncoprotein. Taken together, both HPV16 E6 and
E7 oncoproteins are being expressed and are functional in A549
and BEAS-2B transfected cells.
BEAS-2B cell lines transfected with pLXSNE6E7 constructs
show increased hTERT and p16
INK4a expression
In order to determine if HPV16 E6/E7 expression is able to
alter the level of other genes in lung cells that are currently
overexpressed in HPV-associated tumorigenesis, we evaluated
changes in the expression level of telomerase and p16
INK4a.A s
shown in Fig. 3, even though the tumoral A549 cells constitutively
express hTERT, the levels of these transcripts were not
significantly increased after transfection with HPV16 E6 and
E6/E7 oncogenes (p.0.05). However, BEAS-2B cells showed a
statistically significant increase of telomerase transcripts as shown
using qRT-PCR (Fig. 3A). In addition, p16
INK4a showed a
significant increase after transfection of BEAS-2B cells with E6
and E7 oncogenes (Fig. 3B). Because A549 cells have a deletion
into the region encoding for p16
INK4A, this gene was not evaluated
in these cells. Thus, the HPV16 E6 oncoprotein is able to induce
hTERT expression in non-tumoral lung cells. Because of the
increased hTERT expression in HPV16 pLXSE6E7 transfected
cells, we worked with these constructs for subsequent experiments.
Lung cells transfected with pLXSNE6E7 show increased
proliferation rate
Using MTS assays we checked the viability and proliferation
rate of HPV16 E6/E7 transfected cells and were compared with
those transfected with the empty vector. We found that both A549
and BEAS-2B E6/E7 transfected cells showed a statistically
significant increase of proliferation rate compared to the
corresponding empty vector (Fig. 4). The viability of A549 cells
transfected with E6/E7 cultured during 72 h was increased in all
the concentration range (Fig. 4A). In addition, A549 cells showed
an increased proliferation rate until 120 h of incubation (Fig. 4C).
Non-tumoral BEAS-2B cells showed an increase in viability and
proliferative behavior when transfected with HPV16 E6/E7, even
though this change was less evident compared to tumoral A549
cells (Fig. 4B and D).
Lung cells transfected with PLXSNE6E7 and acutely
exposed to CSC increase significantly the proliferation
rate
In order to determine the CSC concentration to be used in the
transfected cells, we assayed the viability of A549 and BEAS-2B
lung cells at concentrations ranging from 0.1 to 100 mg/mL CSC.
As observed in Fig. 5, as the CSC concentration increases, the
viability of both cell lines decreases. However, we observed that
between 0.1 to 10 mg/mL CSC did not significantly change the
viability of these cells. In addition, this CSC concentration is in the
range of physiological concentration that has been found in
smoker subjects [28,29,30,31]. Thus, in the subsequent experi-
ments we used these CSC concentrations. When A549 and BEAS-
2B serum-starved cells were transfected with E6/E7 and exposed
to 0.1 and 10 mg/mL of CSC for 24, 48 or 72 h, a significant
increase of viability was observed in comparison to non-exposed or
non-transfected cells (Fig. 6). These differences were statistically
significant (p,0.001 or p,0.01). For A549 cells the maximum
viability increase occurred when the cells were exposed to 0.1 mg/
mL CSC (Fig. 6C); for BEAS-2B this increase occurred at 10 mg/
mL CSC (Fig. 6B). Because the MTS-based proliferation method
that we used is able to measure metabolic activity of viable cells,
we confirmed these data using FACS. As shown in Fig. 7, A549
cells showed a significant increase in proliferation rate when
transfected with pLXSN E6E7 and exposed to 0.1 mg/mL of CSC
with respect to those cells transfected with the empty vector and
exposed to CSC (p,0.0001).
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exposed to CSC increase significantly anchorage-
independent growth
The tumoral A549 cells formed colonies in soft agar after
transfection with pLXSN empty vector; however these colonies
significantly increased in number in the presence of E6 and E7.
Moreover, when A549 cells were exposed to 0.1 mg/mL CSC, the
number of colonies was increased in mock and E6/E7 transfected
cells, although this increase was significantly greater in E6/E7
transfected cells (p,0.01, Fig. 8A). In addition, BEAS-2B
developed a low number of colonies in the presence of empty
pLXSN vector. In the presence of E6/E7 the cells showed an
increased ability to grow in soft agar. When these E6/E7
transfected BEAS-2B cells were exposed to 10 mg/ml CSC, they
showed an increased ability of anchorage-independent growth
(p,0.05). However, BEAS-2B showed a less evident anoikis loss in
the presence of E6/E7 and CSC compared to the tumoral A549
cells. Taken together, the A549 and BEAS-2B cells showed more
anchorage independent growth in the presence of E6/E7 and
when they were acutely exposed to CSC.
Discussion
Previously we reported that HPV is present in subsets of lung
carcinomas from some Latin American and Asian Countries. In
addition, HPV was frequently integrated into the host genome
with a low viral load [13,32,33]. Thus it seems plausible that this
Figure 1. HPV-16 E6 and E7 transcripts are detected in lung cells stably transfected with pLXSNE6E7 constructs. A, B: Reverse-
transcriptase PCR for HPV16 E6, E7 and GAPDH transcripts in A549 (A) and BEAS-2B (B) cells. C, D: qRT-PCR for HPV16 E6 (C) and E7 (D) mRNA in A549
and BEAS-2B cells transfected with pLXSNE6E7 constructs (mean 6 SD).
doi:10.1371/journal.pone.0038178.g001
Figure 2. HPV16 E6 and E7 oncoproteins have functional activity in lung cells. A: Western blot for p53 protein in A549 and BEAS-2B
transfected cells with the corresponding construct. B: Transcriptase-reverse PCR for p53 transcripts in A549 and BEAS-2B transfected cells.
doi:10.1371/journal.pone.0038178.g002
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HPV has been detected in non-smoking and smoking subjects, the
role of HPV in tobacco smoke associated carcinogenesis is frankly
unknown [13]. An additional difficulty is the definition of the
condition ‘‘smoker’’ or ‘‘non-smoker’’; frequently this definition is
based on clinical information submitted by the patients, so
potential environmental exposition to tobacco smoke is possibly
underestimated. Thus in this study we analyzed the possibility of a
functional cooperation between HPV and tobacco smoke in lung
epithelial cells. We transfected lung epithelial cells with constructs
stably expressing HPV16 E6 and E7 oncoproteins that were
subsequently exposed to CSC. Our findings showed that
expression of high-risk E6 and E7 oncoproteins is associated with
changes in the expression level and stability of important genes
such as p53, involved in cell cycle regulation (Figs. 1 and 2). In
addition, hTERT and p16
INK4a expressions were strongly induced
in non-tumoral lung cells (Fig. 3). Previously it was reported that
the high-risk E6 oncoprotein is able to cooperate with c-myc to
induce telomerase expression in primary human keratinocytes
[34]. Moreover, telomerase overexpression was demonstrated to
occur in lung carcinomas associated with E6 expression [20]. On
the other hand, p16
INK4a is a cyclin-dependent kinase inhibitor
protein currently up-regulated in HPV-associated malignancies.
We found that in BEAS-2B cells mRNA of this protein increased
significantly its levels after transfection with the E6/E7 construct.
Taken together, here we confirmed that E6 and E7 were
Figure 3. Telomerase (hTERT) and p16
INK4a transcripts are overexpressed in A549 and BEAS-2B cells transfected with pLXSNE6E7
constructs. A: hTERT mRNA detection is significantly increased in BEAS-2B cells transfected with HPV16 E6E7 constructs as detected using qRT-PCR
(p=0.0052). B: p16
INK4a detection is significantly increased in BEAS-2B cells as detected using qRT-PCR (mean 6 SD, p,0.0001, unpaired two-tailed
Student’s t-test).
doi:10.1371/journal.pone.0038178.g003
Figure 4. A549 and BEAS-2B lung cells transfected with pLXSNE6E7 constructs show an increased proliferation rate using MTS
assays (mean 6 SE). A, B: Viability of A549 (A) and BEAS-2B (B) lung cells transfected with the empty vector and pLXSNE6E7 constructs. C, D:
Proliferation curves of A549 (C) and BEAS-2B (D) cells transfected with PLXSNE6E7 and empty vectors (mean 6 SD, * p,0.05; ** p,0.01, *** p,0.001,
unpaired two-tailed Student’s t-test).
doi:10.1371/journal.pone.0038178.g004
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level with telomerase and p16IN4a overexpression.
When HPV16 E6/E7 transfected cells were exposed to CSC,
the proliferative rate and anchorage-independent growth were
significantly increased. In this respect, early studies carried out by
Li et al. demonstrated that HPV was able to transform oral
keratinocytes exposed to benzopyrene [35]. In addition, Park
et al., reported that high-risk HPV immortalized oral cells may
convert to a tumorigenic phenotype by chronic exposure to
benzopyrene [36] or tobacco-related carcinogens [37]. Later it was
reported that both benzopyrene and HPV infection contribute to
the acquisition of an anti-apoptotic phenotype in oral cells [38].
Recently it was found that exposure of epithelial aerodigestive cells
to CSC, activated the NF-kB pathway [39].
In our study, the analysis of proliferation rate, anchorage-
independent loss and FACS suggest an additive effect between
HPV16 E6/E7 oncoproteins and CSC for lung tumorigenesis.
Interestingly, as commented before, tobacco smoke induces p53
accumulation because of its genotoxic effect on epithelial lung
cells. However, high-risk E6 induces p53 degradation and thus
prevents apoptosis of high-risk HPV infected cells. Taken together,
accumulation of genotoxic damage in cells exposed to tobacco
smoke is probably more intensive in HPV16 E6/E7 expressing
cells. The translational implications of these findings remain to be
elucidated.
Even though the International Agency for Research on Cancer
(IARC) identified tobacco smoke a as carcinogen to humans [40],
the mechanism for tobacco smoke-mediated carcinogenesis
remains unclear. It is known that smoking is associated with
molecular alterations related to stimulation of cell proliferation,
thus multiple stages and pathways are involved. More than 4000
compounds have been identified in tobacco smoke; more than
Figure 5. Viability of BEAS-2B (A) and A549 (B) lung cells transfected with pLXSN constructs and exposed to cigarette smoke
condensate (range: 0–100 mg/mL) (mean 6 SD, unpaired two-tailed Student’s t-test). NS: Non-significant.
doi:10.1371/journal.pone.0038178.g005
Figure 6. A549 (A, C) and BEAS-SB (B, D) cells transfected with pLXSNE6E7 constructs and exposed to 0.1 and 10 mg/mL CSC show
an increased viability and proliferation rate (mean 6 SD, * p,0.05; ** p,0.01, *** p,0.001, unpaired two-tailed Student’s t-test).
doi:10.1371/journal.pone.0038178.g006
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involved in initiation, promotion or progression of tumors [21].
Some tobacco compounds cause adducts in the DNA after
activation by cytochrome P450 enzymes to form electrophilic
molecules. The adduct formation may be related to TP53 or K-
Ras mutations, as observed in patients with lung cancer [41]. In
addition to DNA alterations, some components of tobacco such as
nicotine are able to stimulate mitogenic responses and promote
Figure 7. CFSE-labeled A549 cells transfected with empty vector and pLXSNE6E7 were exposed during 48 h to 0.1 mg/mL of CSC. A
representative histogram is shown (mean 6 SD, unpaired two-tailed Student’s t-test).
doi:10.1371/journal.pone.0038178.g007
Figure 8. HPV-16 E6 and E7 expression in A549 (A) and BEAS-2B (B) cells exposed to CSC promotes an increased anchorage-
independent growth. Below: Number of colonies per plate in A549 (left) and BEAS-2B (right) (mean 6 SD, unpaired two-tailed Student’s t-test.
Each plate is representative of three independent experiments).
doi:10.1371/journal.pone.0038178.g008
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epidermal growth factor receptor (EGFR) and the nicotinic
acetylcholine receptor (nAChR). Because the expression of these
receptors is tissue-dependent, the response to cigarette smoke
components such as nicotine shows tissue specificity [42]. The
EGFR, whose expression is altered in malignancies, activates both
the phosphatidylinositol-3 kinase (PI3K) and mitogen-activated/
extracellular signal-regulated kinase (MAPK) pathways, which can
potentially modulate activation of nuclear factors kB (NF-kB) and
AP-1, respectively. On the other hand, it has been found that
nAChR, an ion channel located in plasmatic membranes, is widely
distributed in epithelial cells, keratinocytes, endothelial and non-
small cell lung carcinomas (NSCLCs) [43], explaining the widely
distributed tobacco smoke-associated diseases, including cancer
[42]. It has been reported that both nicotine and 4-(Methylni-
trosamino)-1-(3-pyridyl)-1-butanone (NNK) are able to induce
lung cancer by binding to nAChR and activating PKC, Raf1,
AKT, ERK1/2, and transcription factors such as Jun, Fos, and c-
Myc [21,42,43,44]. In addition, nicotine, nitrosamines and PAH
can activate beta-adrenergic receptors (b-AR) and the aril-
hydrocarbon receptor (AhR). The first of these is activated by
catecholamines and NNK. AhR is a ubiquitous protein involved in
regulating expression of genes associated with activation and
detoxification of carcinogens [45]. In this respect, using micro-
arrays it has been reported that high-risk HPV E6 and E7
oncoproteins are able to deregulate the AhR pathway in SCLC, a
tumor strongly associated with the smoking habit [46].
Even though in this study a significant increase in proliferative
rate and anchorage-independent growth was found, the mere
expression of E6 and E7 oncoproteins was sufficient for alterations
in the analyzed properties of lung cells. In consequence, is not
possible to discard the possibility that E6 and E7 oncoproteins act
independently of tobacco smoke. In fact, Ciotti et al using
proteomic analysis reported that E6 and E7 oncogenes when
overexpressed in A549 lung cells are able to upregulate the levels
of Annexin III, gp96, transaldolase 1, between others [47]. In our
study, a dramatic increase of proliferation and anchorage-
independent growth was observed only after E6/E7 transfections
(and hTERT overexpression), and acute cigarette smoke exposi-
tion incremented these properties.
A very important issue is if the CSC concentrations that were
used in this study represent a real physiological exposure to
tobacco smoke. The concentration of CSC is 40 mg/mL which
corresponds to 6.4% of nicotine. In this report, lung cells were
exposed to 0.1 and 10 mg/mL CSC which corresponds to 0.064
and 0.64 mg/mL nicotine. It has been reported that nicotine
concentration ranged between 0.6 to 1.0 mg/mL into the tissue of
smokers and 0.04 to 0.072 mg/mL in serum [28,29]. Thus, the
CSC concentrations used in this study are compatible with real
physiological conditions.
In conclusion, in this study a functional cooperation between
HPV16 E6/E7 oncoproteins and CSC, leading to an increase of
proliferation rate and anchorage-independent growth of lung cells
was shown. According to our knowledge, this is the first report
addressing a potential cooperation between HPV and tobacco
smoke in lung epithelial cells. Considering that HPV16 E6 and E7
oncoproteins are detected in a subset of lung carcinomas from
subjects around the world who smoke or are exposed to tobacco
smoke, they appear to be able to modulate the proliferative and
tumoral behavior of cells exposed to tobacco smoke in bronchial
epithelia. So it is plausible that in smoking subjects exposed to
HPV infection, a functional interaction increases the possibility of
carcinogenic progression. Additional functional and epidemiolog-
ical studies are warranted to resolve this question.
Materials and Methods
Cell culture and transfections
Human cell lines A549 (lung adenocarcinoma, CCL-185),
BEAS-2B (normal bronchial tissue, CRL-9609) and SiHa (HPV16
positive cervical carcinoma, HTB-35) were directly obtained from
the American Type Culture Collection (ATCC) (Manassas, VA).
These cell lines were maintained in RPMI-1640 (Invitrogen)
supplemented with 10% inactivated fetal bovine serum (FBS)
(Hyclone), 0.1 mg/mL gentamicin (Invitrogen), 1 U/mL penicillin
and 1 mg/mL streptomycin (Invitrogen) and incubated at 37uCi n
a5 %C O 2 atmosphere incubator. The cells were checked for
mycoplasma infection using standardized protocols. A549 and
BEAS-2B cells were transfected with the retroviral vectors pLXSN
and pLXSN containing the HPV-16 E6/E7 ORFs (pLXSNE6,
pLXSNE7 and pLXSNE6E7) (kindly provided by Dr. Massimo
Tommasino; IARC, Lyon, France). Transfection assays were
made using lipofectamine 2000 (Invitrogen) according to the
manufacturer’s instructions. Briefly, one day before transfection
cells were seeded in six-well plates with 3 mL of basal RPMI-1640
medium without antibiotics. For each plate, 4 mg of pLXSN
recombinant plasmids were mixed with 250 mL of RPMI-1640
basal medium without antibiotics. The mixture was then
combined with 10 mL of lipofectamine 2000 (Invitrogen) in
250 mL of RPMI-1640 and incubated for 20 min at room
temperature. The plasmid mixture was directly added to the cells
containing RPMI-1640 supplemented with 5% FBS without
antibiotics. The cells were incubated for 18 h at 37uC and then
the cell culture medium was discarded; the cells were washed with
phosphate buffered saline pH 7.4 (PBS) and incubated with
RPMI-1640 supplemented with 5% FBS and 0.5 mg/mL G418
for selection. After 2 to 3 weeks, the resulting colonies were pooled
and used for subsequent analysis.
RNA purification, cDNA preparation and reverse-
transcriptase polymerase chain reaction (PCR)
Cellular RNA was isolated using 1 mL of Trizol reagent
(Invitrogen) according to the manufacturer’s instructions. The
RNA concentration and purity was determined using a Nano-
drop1000 spectrophotometer (Thermo Scientific) and 2 mgo f
RNA was treated with RQ1 DNAse (Promega) at 37uC for 1 h
and denatured at 65uC. cDNA was synthesized in a 20 mL
reaction volume containing DNAse-treated RNA (2 mg), 1 U
RNAse inhibitor (Promega), 0.04 mg/mL random primers (Pro-
mega), 2 mM dNTP (Promega) and 10 U Moloney murine
leukemia virus (MMLV) reverse transcriptase (Promega). The
reaction mixture was incubated for 1 h at 37uC followed by
incubation at 65uC for 10 min. The cDNA samples were subjected
to PCR amplification with specific primers for HPV16 E6/E7,
p53 and GAPDH (Table 1). For GAPDH cDNA amplification,
1 mL of the prepared cDNA was added to a tube containing 1X
reaction buffer; 2.5 mM MgCl2; 0.2 mM dNTP; 0.52 mM primer
pairs, and 0.08 U GoTaq Flexi DNA polymerase (Promega). PCR
amplification was performed under the following conditions:
denaturation at 94uC for 5 min followed by 35 cycles of 94uC
for 30 s, 55uC for 30 s, 72uC for 30 s and final extension for 5 min
at 72uC. For E6, E7 and p53 cDNA amplification, we used 1 mL
of cDNA, 1X GoTaq Flexi buffer; 0.2 mM dNTP; 2.5 mM
MgCl2; 0.5 mM primers and 0.08U GoTaq Flexi DNA polymer-
ase (Promega). PCR amplification was performed under the
following conditions: denaturation at 95uC for 5 min, followed by
35 cycles at 95uC for 1 min, 55uC for 1 min, 72uC for 1 min and
final extension for 10 min at 72uC. Amplified products were
characterized using 3% agarose gel electrophoresis, stained with
Interaction between HPV Oncoproteins and Tobacco
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(Vilver Lourmat).
Quantitative real-time PCR (qRT-PCR)
The primers used for E6, E7, hTERT and p16
INK4a amplifi-
cation were described in Table 1. For hTERT, the reaction
mixture was prepared as follows: 0.4 mM primer F, 0.4 mM primer
R, 1.5 mM MgCl2, 1X SensiMix (Bioline, Taunton, Massachu-
setts, USA) and 1 mL cDNA. PCR amplification was performed as
follows: 10 min incubation at 95uC; 45 cycles of 15 s at 95uC, 20 s
at 55uC and 20 s at 72uC. For p16, E6, E7 and GAPDH the
reaction mixture was prepared as follow: 0.5 mM primer F,
0.5 mM primer R, 1.5 mM MgCl2, 1X SensiMix and 1 mL cDNA.
For p16
INK4a, the PCR amplification was performed as follows:
10 min incubation at 95uC; 45 cycles of 10 s at 95uC, 10 s at 55uC
and 10 s at 72uC. For E6 and E7 the amplification conditions were
the same that were used for hTERT. GAPDH amplification was
used for data normalization. The PCR amplification was
performed as follows: 10 min incubation at 95uC; 45 cycles of
15 s at 95uC, 20 s at 55uC and 20 s at 72uC. The PCR reactions
were carried out using Rotor Gene 6000 (Corbett Research) real-
time PCR equipment. The specificity of amplification was
confirmed using dissociation analysis starting at 60uC.
Protein purification and Western Blotting (WB)
Total protein was extracted from cells with a lysis buffer
(100 mmol/L Tris pH 8.0, 1% SDS) containing a protease
inhibitor cocktail (Sigma-Aldrich). The cells were incubated at
4uC for 1 h, sonicated on ice for 20 s and centrifuged at 12,000 G
for 10 min. The protein concentration was determined using
Pierce BCA protein Assay Reagent kit (Thermo). For p53 blots;
25 mg of the extract was loaded per well on 10% polyacrylamide
gels. Following SDS-PAGE, proteins were transferred onto a
nitrocellulose membrane in a Trans-Blot semi-dry electrophoretic
transfer cell (BioRad) (20 min, 15 V). The membranes were
blocked in 5% dry milk–TBS–Tween 20 and incubated for 16 h at
4uC with a primary monoclonal anti-p53 antibody (DO7 clone)
diluted 1:1000 (BD Biosciences). After extensive washing with
TBS-Tween 20, the membrane was developed using an ECL kit
according to the manufacturer’s instructions (Amersham Biosci-
ences). b-actin (1/10.000) (Abcam) was probed in all samples to
exclude false negative results and cell lysates from CasKi cells
(containing HPV16) were used as positive controls.
Smoke exposures and CSC preparation.
The transfected A549 and BEAS-2B cell lines were maintained
at 80–90% confluence with RPMI-1640 basal medium, serum-
starved for 24 h previous to CSC (Murty Pharmaceutical,
Lexington, KY, USA) exposition. The CSC dilutions in basal
RPMI-1640 medium were freshly prepared for each experiment in
a range from 10
23 to 50 mg/mL using a 40 mg/mL stock solution.
Dimethyl-sulfoxide (DMSO) was used as negative control. The
CSC stock solution was aliquoted and stored light-protected at
280uC.
Cytotoxicity CSC assays
A549 and BEAS-2B transfected cells were trypsinized with an
EDTA-trypsin mixture (Invitrogen) and counted using Trypan
blue exclusion staining with a Neubauer chamber. Briefly, 5610
3
cells were prepared and incubated on 96-well plates with RPMI-
1640 (Invitrogen, Grand Island, NY, USA) supplemented with
10% FBS (Hyclone, Logan, UT, USA), penicillin/streptomycin
mixture and 0.1 mg/mL gentamicin (Invitrogen). The CSC was
added to the cells and incubated at 37uC in a 5% C02 atmosphere
incubator. After 72 h of incubation, thirty mL of MTS reagent
(Promega) were added to each well and the plate was incubated for
three h at 37uC; the absorbance was measured at 492 nm using a
microplate reader (model Anthos 2001).
Viability and proliferation assays
Transfected cell lines were grown to 80–90% confluence and
incubated with serum-starved RPMI-1640 medium in 60 mm
plates for 24 h. The cells were trypsinized with EDTA-trypsin
mixture (Invitrogen) and counted using Trypan blue exclusion
staining with a Neubauer chamber. 5610
3 cells were cultured in a
96-well flat-bottomed microtiter plate with RPMI-1640 basal
medium and alternately supplemented with 0.1 and 10 mg/ml of
CSC for periods ranging from 24 to 120 h, using DMSO as
control. Finally, thirty mL of [3-(4,5-dimethylthiazol-2-yl)-5-(3-
carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium, inner
salt; MTS] (Promega) were added to each well, the plate was
incubated for 3 h at 37uC and the absorbance was measured at
492 nm using a microplate reader (Anthos 2001).
CFSE proliferation assays
A549 transfected and non-transfected cells were passaged at 80–
90% confluence in 60 mm plates without serum for 24 h at 37uC
in a 5% CO2 atmosphere incubator. Then the cells were
trypsinized with EDTA-trypsin 1X (Invitrogen) and counted using
trypan blue staining. 1610
6 cells were treated with 0.5 mM
carboxifluorescein succinimidyl ester (CFSE) for 10 min at 37uC.
Then 5610
4 cells were deposited in 6-well plates in RPMI-1640
basal medium with 10% FCS and exposed to 0.01 and 10 mg/mL
CSC during 48 h. The cells were washed with 1X PBS, suspended
with 1X trypsin-EDTA and analyzed by flow cytometry in the
FACS Cantoll equipment. (Beckett Dickinson, Mississauga,
Ontario, USA), considering a universe of 10,000 cells.
Anchorage-independent growth assays
The transfected cells exposed to 0.01 and 10 mg/mL of CSC for
72 h were trypsinized using 1X Trypsin-EDTA mixture and
counted using trypan blue staining. Thus 1610
4 cells were
suspended in 0.33% Bacto-agar dissolved in a mixture containing
Table 1. Primers used in this study.
Gene Primer sequence
Size
product
(bp)
GAPDH Sense CGGGAAGCTTGTCATCAATGG
Antisense CATGGTTCACACCCATGACG 221
E6 Sense CAACAAACCGTTGTGTGAT
Antisense CGTGTTCTTGATGATCTGC 162
E7 Sense ATG CATGGAGATACACCTAC
Antisense CATTAACAGGTCTTCCAAAG 252
p53 Sense GGAGCCGCAGTCAGATCCTA
Antisense GGGGACAGAACGTTGTTTTC 96
p16
INK4a Sense TCGGGTCGAGGAAGGTGA
Antisense TCATGATGATGAGGGCAGCG 102
hTERT Sense GCGGAAGACAGTGGTGAACT
Antisense ACCTGGAGTAGTCGCTCTGC 150
doi:10.1371/journal.pone.0038178.t001
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supplemented with 0.01 or 10 mg/mL CSC. The cells were
cultured in six-well plates containing 0.5% agar for 1 month. The
cells were fed twice each week with 0.5 mL of RPMI-1640-10%
FBS supplemented with 0.01 or 10 mg/mL CSC. Finally, the cells
were stained using 0.005% crystal violet for 1 h and photographed.
Statistical analysis
Overall numeric data were analyzed considering averages and
standard deviations. The comparison between CSC treated groups
and controls were made considering a non-paired statistical
analysis with 95% confidence interval using Prism 4.0 software
(GraphPad Software, San Diego, CA, USA). A p value less than
0.05 was considered as statistically significant.
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